Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01292681
What this trial is testing

Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Radboud University Medical Center 60
Not applicableStudy completedNCT06370234
What this trial is testing

The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.

Who this might be right for
Breast CancerChemotherapy EffectDiffusion Weighted MRI+2 more
National Taiwan University Hospital 60
Not applicableUnknownNCT04735900
What this trial is testing

Lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Antwerp 60
Very early researchStudy completedNCT00620243
What this trial is testing

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 9
Not applicableLooking for participantsNCT07159048
What this trial is testing

The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

Who this might be right for
Hepatocellular CarcinomaColorectal Cancer Liver Metastasis
Fudan University 120
Large-scale testing (Phase 3)Looking for participantsNCT05125055
What this trial is testing

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT00721799
What this trial is testing

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

Who this might be right for
Mouth NeoplasmsOropharyngeal NeoplasmsLaryngeal Neoplasms+1 more
University of Iowa 33
Not applicableUnknownNCT00336206
What this trial is testing

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Tawam Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT02325349
What this trial is testing

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

Who this might be right for
Advanced Head and Neck CarcinomaAdvanced Non-small Cell Lung Carcinoma
Assistance Publique - Hôpitaux de Paris 1
Testing effectiveness (Phase 2)Looking for participantsNCT05420948
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
University of Chicago 30
Not applicableLooking for participantsNCT04517838
What this trial is testing

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2-Positive Breast CarcinomaAnatomic Stage I Breast Cancer AJCC v8+3 more
Mayo Clinic 230
Not applicableStudy completedNCT02840058
What this trial is testing

Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1

Who this might be right for
Cancer
Centre Hospitalier Universitaire de Besancon 295
Testing effectiveness (Phase 2)Ended earlyNCT00589238
What this trial is testing

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 16
Testing effectiveness (Phase 2)Looking for participantsNCT06923787
What this trial is testing

Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study

Who this might be right for
Colon Cancer
Institute of Oncology Ljubljana 100
Not applicableStudy completedNCT02952521
What this trial is testing

Ovarian Tumor Biopsies to Study Response to Treatments

Who this might be right for
Epithelial Ovarian Cancer
University Health Network, Toronto 5
Testing effectiveness (Phase 2)Ended earlyNCT05300958
What this trial is testing

Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Not applicableLooking for participantsNCT07737509
What this trial is testing

Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample Analysis

Who this might be right for
Advanced Solid Tumours
Institute of Cancer Research, United Kingdom 5,000
Not applicableEnded earlyNCT03862066
What this trial is testing

Memory Phenotype and PD-1 Inhibition Response in Oral Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Medical University of South Carolina 2
Next Page